Published 2013
| Version v1
Publication
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines
Additional details
- URL
- http://hdl.handle.net/11567/999686
- URN
- urn:oai:iris.unige.it:11567/999686
- Origin repository
- UNIGE